MultiQure S.A. (WSE: MQR)
Health Care · Biotechnology · PL
zł1.52
-0.52% today · -75.3% 1Y
MultiQure S.A. (WSE: MQR) operates in the Biotechnology industry within the Health Care sector. The company is valued at $88.26M and employs 7 people.
Over the last twelve months the share price has lost 75.3%, trading between 1.29 and 6.62.
Tweenvest scores MultiQure S.A. across four factors: quality 19/100, value 50/100. Its strongest factor is value.
MQR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $88.26M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -16.15
- Dividend yield
- —
- Beta (5Y)
- 0.30
- 52-week high
- zł6.62
- 52-week low
- zł1.29
- Avg volume (3M)
- —
- Shares outstanding
- 225.75M
- Employees
- 7
- Next earnings
- —
About MultiQure S.A.
Pure Biologics Spólka Akcyjna operates as a biopharmaceutical enterprise, concentrating its efforts on the discovery and development of novel biological pharmaceuticals and targeted, non-systemic treatments. The company's key therapeutic interests span immuno-oncology, various autoimmune conditions, and rare diseases. Its capabilities encompass the entire process for antibodies and aptamers, from their initial creation and purification to detailed analysis and characterization. Additionally, Pure Biologics is skilled in the design, development, and rigorous validation of diagnostic and research assays, while also advancing technology platforms for the precise selection of active therapeutic molecules. A significant offering is PureApta, a adaptable platform engineered for the in vitro selection of modified aptamers, suitable for both medical treatment and diagnostic applications. The firm is also actively pursuing the development of localized therapies aimed at assisting individuals afflicted by neurological autoimmune disorders, including conditions like neuromyelitis optica and myasthenia gravis. Founded in 2010, Pure Biologics Spólka Akcyjna is headquartered in Wroclaw, Poland.
- ISIN
- PLPRBLG00010
- Founded
- 2010
- Listed since
- Dec 10, 2018
- Exchange
- Warsaw Stock Exchange
- Currency
- PLN
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PMV Pharmaceuticals, Inc.NasdaqGS: PMVP | $91.37M | $1.21 | -20.39% |
| Genexine, Inc.KOSDAQ: A095700 | $90.23M | ₩2,645.00 | -8.95% |
| Tonix Pharmaceuticals Holding Corp.NasdaqGS: TNXP | $88.67M | $5.17 | +0.78% |
| Energenesis Biomedical CO.,LTD.TWSE: 6657 | $88.46M | NT$32.65 | -6.31% |
| Corbus Pharmaceuticals Holdings, Inc.NasdaqCM: CRBP | $87.42M | $4.52 | -15.99% |
| Revium Rx.OTCPK: RVRC | $86.84M | $— | — |
| Rallybio CorporationNasdaqCM: RLYB | $86.45M | $16.28 | -4.35% |
| Wuhan YZY Biopharma Co., Ltd.SEHK: 2496 | $86.45M | HK$3.50 | +40.00% |
Figures last refreshed Oct 18, 2026.